---
company: Westlake Chemical Partners LP
ticker: WLKP
form: 8-K
filed: 2026-08-04
accession: 0001604665-26-000022
source: https://www.sec.gov/Archives/edgar/data/1604665/000160466526000022/
---

# Westlake Chemical Partners (WLKP) earnings release, August 4, 2026

Westlake Chemical Partners LP (WLKP) · Form 8-K, Item 2.02 · Filed 2026-08-04 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1604665/000160466526000022/)

WESTLAKE CHEMICAL PARTNERS LP

Contact—(713) 585-2900

Investors—Jonathan Baksht

Media—L. Benjamin Ederington

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

• Declared quarterly distribution of

$0.4714 per unit; 48 th consecutive quarterly distribution

HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2026 of $14.2 million, or $0.40 per limited partner unit, which was slightly below second quarter 2025 net income of $14.6 million. Cash flows from operating activities in the second quarter of 2026 were $129.8 million, an increase of $120.7 million compared to second quarter 2025 cash flows from operating activities of $9.1 million, primarily due to higher production and sales volume and lower maintenance capital expenditures as the result of the prior year's Petro 1 turnaround. For the three months ended June 30, 2026, MLP distributable cash flow was $17.6 million, an increase of $2.6 million compared to second quarter 2025 MLP distributable cash flow of $15.0 million. The increase in MLP distributable cash flow and associated trailing twelve-month coverage ratio of 1.04x was primarily due to higher production and sales volume and lower maintenance capital expenditures as a result of the prior year's Petro 1 turnaround.

Compared to the first quarter, second quarter 2026 net income attributable to the Partnership was unchanged at $14.2 million. Second quarter 2026 cash flows from operating activities of $129.8 million increased by $19.6 million due to working capital changes. Second quarter 2026 MLP distributable cash flow of $17.6 million decreased by $0.3 million compared to first quarter 2026 MLP distributable cash flow of $17.9 million due to higher maintenance capital expenditures.

"We were pleased with the Partnership's performance in the second quarter as we benefited from higher third-party ethylene prices and the continued stability of our cash flows due to the ethylene sales agreement with Westlake," said Jean-Marc Gilson, President and Chief Executive Officer. "Looking forward, we expect to continue to provide strong returns and predictable cash flows to our unitholders."

On July 8, 2026, both the Partnership and Westlake Chemical OpCo LP ("OpCo") entered into amendments to their respective senior unsecured revolving credit agreements with Westlake Corporation. These amendments extended the maturity dates of the facilities to July 2031.

On August 3, 2026, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the second quarter of 2026 of $0.4714 per common unit to be payable on August 28, 2026 to unitholders of record as of August 13, 2026, representing the 48th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage that was 1.04x the declared distributions for the second quarter of 2026, which was above the trailing twelve-month coverage ratio of 1.00x at the end of the first quarter. Since our IPO in July of 2014 our cumulative coverage ratio is approximately 1.05x.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures. i

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to: our financing arrangements with Westlake; the timing and results of our turnaround activities, our outlook for third-party ethylene margins, the impact of the conflict in the Middle East on global demand for our products, our expectations regarding feedstock and energy costs, our ability to deliver value, returns, predictable cash flows and distributions to unitholders; our relationship with Westlake and the benefits of the ethylene sales agreement, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: operating difficulties or disruptions; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake, including determinations made pursuant to contractual arrangements with Westlake; the effects of legal proceedings; actions of third parties; inclement or hazardous weather conditions; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; inability of our customers to take delivery; fires, explosions or other industrial accidents; political tension and conflict in the Middle East and elsewhere; the supply/demand balance for our products; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC in March 2026, and the Partnership’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, which was filed with the SEC in May 2026.... (truncated) United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow, coverage ratio and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow, coverage ratio and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a

22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com. ii

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' second quarter 2026 results will be held Tuesday, August 4, 2026 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register-conf.media-server.com/register/BI51826be52fb84f029203dae034f42aa3.

A dial-in will be provided upon registration.

The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/ssbetq3b and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx. iii

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

## Financial statements

### Income Statement (Three Months Ended June 30, — (Unaudited) (in thousands))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | Net sales—Westlake Corporation ("Westlake") | 238,030 | 269,076 | 501,121 | 459,857 |
| Revenue | Net co-products, ethylene and other sales—third parties | 59,070 | 28,043 | 101,654 | 74,891 |
| Revenue | Total net sales | 297,100 | 297,119 | 602,775 | 534,748 |
| Revenue | Cost of sales | 202,295 | 199,587 | 414,211 | 383,135 |
| Revenue | Gross profit | 94,805 | 97,532 | 188,564 | 151,613 |
| Revenue | Selling, general and administrative expenses | 7,494 | 6,300 | 14,684 | 13,774 |
| Revenue | Income from operations | 87,311 | 91,232 | 173,880 | 137,839 |
| Other income (expense) | Interest expense—Westlake | -5,119 | -5,907 | -10,204 | -11,444 |
| Other income (expense) | Other income, net | 348 | 675 | 696 | 2,021 |
| Other income (expense) | Income before income taxes | 82,540 | 86,000 | 164,372 | 128,416 |
| Other income (expense) | Provision for income taxes | 178 | 205 | 355 | 312 |
| Other income (expense) | Net income | 82,362 | 85,795 | 164,017 | 128,104 |
| Other income (expense) | Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo") | 68,124 | 71,237 | 135,610 | 108,598 |
| Other income (expense) | Net income attributable to Westlake Partners | 14,238 | 14,558 | 28,407 | 19,506 |
| Net income per limited partner unit attributable to Westlake Partners (basic and diluted) | Common units | 0.4 | 0.41 | 0.81 | 0.55 |
| Net income per limited partner unit attributable to Westlake Partners (basic and diluted) | Distributions declared per unit | 0.4714 | 0.4714 | 0.9428 | 0.9428 |
| Net income per limited partner unit attributable to Westlake Partners (basic and diluted) | MLP distributable cash flow | 17,636 | 15,007 | 35,522 | 19,721 |
| Distributions declared | Limited partner units—publicly and privately held | 9,958 | 9,955 | 19,916 | 19,909 |
| Distributions declared | Limited partner units—Westlake | 6,657 | 6,657 | 13,314 | 13,314 |
| Distributions declared | Total distributions declared | 16,615 | 16,612 | 33,230 | 33,223 |
| Distributions declared | EBITDA | 122,687 | 124,391 | 243,903 | 199,412 |

### Balance Sheet ((Unaudited) (in thousands))

| | June 30, 2026 | December 31, 2025 |
|---|---:|---:|
| Current assets | Cash and cash equivalents | 49,321 | 44,269 |
| Current assets | Receivable under the Investment Management Agreement—Westlake | 43,577 | 23,378 |
| Current assets | Accounts receivable, net—Westlake | 39,464 | 63,571 |
| Current assets | Accounts receivable, net—third parties | 21,602 | 9,113 |
| Current assets | Inventories | 3,563 | 2,769 |
| Current assets | Prepaid expenses and other current assets | 10 | 406 |
| Current assets | Total current assets | 157,537 | 143,506 |
| Current assets | Property, plant and equipment, net | 858,643 | 886,012 |
| Current assets | Other assets, net | 201,168 | 227,015 |
| Current assets | Total assets | 1,217,348 | 1,256,533 |
| LIABILITIES AND EQUITY | Current liabilities (accounts payable and accrued and other liabilities) | 45,768 | 51,301 |
| LIABILITIES AND EQUITY | Long-term debt payable to Westlake | 399,674 | 399,674 |
| LIABILITIES AND EQUITY | Other liabilities | 2,493 | 3,206 |
| LIABILITIES AND EQUITY | Total liabilities | 447,935 | 454,181 |
| LIABILITIES AND EQUITY | Common unitholders—publicly and privately held | 457,957 | 460,848 |
| LIABILITIES AND EQUITY | Common unitholder—Westlake | 38,328 | 40,260 |
| LIABILITIES AND EQUITY | General partner—Westlake | -242,572 | -242,572 |
| LIABILITIES AND EQUITY | Total Westlake Partners partners' capital | 253,713 | 258,536 |
| LIABILITIES AND EQUITY | Noncontrolling interest in OpCo | 515,700 | 543,816 |
| LIABILITIES AND EQUITY | Total equity | 769,413 | 802,352 |
| LIABILITIES AND EQUITY | Total liabilities and equity | 1,217,348 | 1,256,533 |

### Cash Flow (Six Months Ended June 30, — (Unaudited) (in thousands))

| | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|
| Cash flows from operating activities | Net income | 164,017 | 128,104 |
| Adjustments to reconcile net income to net cash provided by operating activities | Depreciation and amortization | 69,327 | 59,552 |
| Adjustments to reconcile net income to net cash provided by operating activities | Net loss on disposition and other | 2,356 | 524 |
| Adjustments to reconcile net income to net cash provided by operating activities | Other balance sheet changes | 4,345 | -133,328 |
| Adjustments to reconcile net income to net cash provided by operating activities | Net cash provided by operating activities | 240,045 | 54,852 |
| Cash flows from investing activities | Additions to property, plant and equipment | -18,037 | -40,336 |
| Cash flows from investing activities | Investments with Westlake under the Investment Management Agreement | -20,000 |  |
| Cash flows from investing activities | Maturities of investments with Westlake under the Investment Management Agreement |  | 90,000 |
| Cash flows from investing activities | Net cash provided by (used for) investing activities | -38,037 | 49,664 |
| Cash flows from financing activities | Proceeds from debt payable to Westlake | 82,000 | 95,000 |
| Cash flows from financing activities | Repayment of debt payable to Westlake | -82,000 | -95,000 |
| Cash flows from financing activities | Distributions to noncontrolling interest retained in OpCo by Westlake | -163,726 | -93,031 |
| Cash flows from financing activities | Distributions to unitholders | -33,230 | -33,222 |
| Cash flows from financing activities | Net cash used for financing activities | -196,956 | -126,253 |
| Cash flows from financing activities | Net increase (decrease) in cash and cash equivalents | 5,052 | -21,737 |
| Cash flows from financing activities | Cash and cash equivalents at beginning of period | 44,269 | 58,316 |
| Cash flows from financing activities | Cash and cash equivalents at end of period | 49,321 | 36,579 |
